The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A Comprehensive Analysis of PAX8 Expression in Human Epithelial Tumors
Abstract
PAX8 is a paired-box gene important in embryogenesis of the thyroid, Müllerian, and renal/upper urinary tracts, and expression of PAX8 has been previously described in carcinomas from each of these sites. However, a large study including a wide variety of epithelial neoplasms from multiple organ sites other than the thyroid, kidney, or Müllerian system has not been performed. The goal of this study was to evaluate the utility of PAX8 immunostaining based on the evaluation of a wide range of epithelial tumors. PAX8 immunohistochemistry was performed on 1357 tumors (486 tumors in whole-tissue sections and 871 tumors in tissue microarrays, predominantly epithelial) from multiple organs. Only nuclear staining was scored as positive, and tumors were evaluated for the extent and intensity of staining. Western blot analysis with PAX8 was also performed on multiple tumor cell lines. Nuclear PAX8 staining was present in 91% (60 of 66) of thyroid tumors, 90% (158 of 176) of renal cell carcinomas (RCCs), 81% (13 of 16) of renal oncocytomas, 99% (164 of 165) of high-grade ovarian serous carcinomas, 71% (32 of 49) of nonserous ovarian epithelial neoplasms, 91% (10 of 11) of cervical epithelial lesions, and 98% (152 of 155) of endometrial adenocarcinomas. Of the remaining 719 evaluated tumors, only 30 cases (4%), including 12 thymic neoplasms, 3 bladder urothelial carcinomas, 4 lung squamous cell carcinomas, 2 esophageal adenocarcinomas, 1 pancreatic adenocarcinoma, 2 cholangiocarcinomas, 1 ovarian Sertoli-Leydig cell tumor, 1 ovarian sex cord stromal tumor, 3 testicular mixed germ cell tumors, and 1 acinic cell carcinoma, showed at least weak or focal PAX8 positivity. The unexpected finding was diffuse, moderate staining of PAX8 in a subset of thymomas and thymic carcinomas. The 689 remaining tumors, including but not limited to those from the prostate, colon, stomach, liver, adrenal gland, and head and neck, and small cell carcinomas from the lung, cervix, and ovary, were PAX8 negative. PAX8 specificity was confirmed by Western blot analysis, as expression was detected only in ovarian and RCC cell lines. These results show that PAX8 is a highly sensitive marker for thyroid, renal, Müllerian, and thymic tumors. Importantly, all lung adenocarcinomas, breast and adrenal neoplasms, and the majority of gastrointestinal tumors were negative for PAX8. Therefore, PAX8 is an excellent marker for confirming primary tumor site. In a subset of cases, additional markers, including but not limited to thyroid transcription factor-1, RCC, and Wilms tumor-1, may be needed to distinguish between the 3 most common PAX8-positive tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Köbel, M., Kalloger, S. E., Boyd, N., McKinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N. J., Ionescu, D. N., Rajput, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050232 · Cited by 814
PAX8-PPAR γ 1 Fusion in Oncogene Human Thyroid Carcinoma
Kroll, T. G., Sarraf, P., Pecciarini, L., Chen, C.-J., Mueller, E., Spiegelman, B. M., & Fletcher, J. A. (2000) · Science · doi:10.1126/science.289.5483.1357 · Cited by 784
Nikiforova, M. N., Lynch, R. A., Biddinger, P. W., Alexander, E. K., Dorn, G. W., Tallini, G., Kroll, T. G., & Nikiforov, Y. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021907 · Cited by 713
Nephric lineage specification by Pax2 and Pax8
Bouchard, M., Souabni, A., Mandler, M., Neubüser, A., & Busslinger, M. (2002) · Genes & Development · doi:10.1101/gad.240102 · Cited by 551
PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis
Macchia, P. E., Lapi, P., Krude, H., Pirro, M. T., Missero, C., Chiovato, L., Souabni, A., Baserga, M., Tassi, V., Pinchera, A., et al. (1998) · Nature Genetics · doi:10.1038/ng0598-83 · Cited by 501
Getting your Pax straight: Pax proteins in development and disease
Chi, N., & Epstein, J. A. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(01)02594-x · Cited by 483
Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland
Plachov, D., Chowdhury, K., Walther, C., Simon, D., Guenet, J.-L., & Gruss, P. (1990) · Development · doi:10.1242/dev.110.2.643 · Cited by 479
New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
Levanon, K., Crum, C., & Drapkin, R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1107 · Cited by 412 · cited 1×
“In addition, multiple studies have shown that these PAX8positive fallopian tube secretory cells are the likely source for many ovarian/pelvic serous tumors.(9,18,22,39) Clinically, PAX8 has been shown to be useful in distinguishing serous ovarian carcinoma from breast carcinoma,(35) malignant mesothelioma,(21) and pri…”
BackgroundSelf-citationAre All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
Przybycin, C. G., Kurman, R. J., Ronnett, B. M., Shih, I.-M., & Vang, R. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181ef7b16 · Cited by 410
Pax genes and their roles in cell differentiation and development
Mansouri, A., Hallonet, M., & Gruss, P. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80087-1 · Cited by 333
Watson, M. A., & Fleming, T. P. (1996) · PubMed · Cited by 309
Ovarian Cancer Pathogenesis: A Model in Evolution
Karst, A. M., & Drapkin, R. (2010) · Journal of Oncology · doi:10.1155/2010/932371 · Cited by 298
Self-citationNonaka, D., Tang, Y., Chiriboga, L., Rivera, M., & Ghossein, R. (2008) · Modern Pathology · doi:10.1038/modpathol.3801002 · Cited by 287
Jones, T. D., Ulbright, T. M., Eble, J. N., Baldridge, L. A., & Cheng, L. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200407000-00014 · Cited by 283
Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study
Tong, G.-X., Yu, W. M., Beaubier, N. T., Weeden, E. M., Hamele-Bena, D., Mansukhani, M. M., & O'Toole, K. M. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.88 · Cited by 238
PAX8 Reliably Distinguishes Ovarian Serous Tumors From Malignant Mesothelioma
Laury, A. R., Hornick, J. L., Perets, R., Krane, J. F., Corson, J., Drapkin, R., & Hirsch, M. S. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181da7687 · Cited by 230
Self-citationPoleev, A., Fickenscher, H., Mundlos, S., Winterpacht, A., Zabel, B., Fidler, A., Gruss, P., & Plachov, D. (1992) · Development · doi:10.1242/dev.116.3.611 · Cited by 229
Trueba, S. S., Augé, J., Mattei, G., Etchevers, H., Martinovic, J., Czernichow, P., Vekemans, M., Polak, M., & Attié-Bitach, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1358 · Cited by 225
Pax2 and Pax8 Regulate Branching Morphogenesis and Nephron Differentiation in the Developing Kidney
Narlis, M., Grote, D., Gaitan, Y., Boualia, S. K., & Bouchard, M. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070739 · Cited by 224
Levanon, K., Ng, V, Piao, H. Y., Zhang, Y., Chang, M. C., Roh, M. H., Kindelberger, D. W., Hirsch, M. S., Crum, C. P., Marto, J. A., et al. (2010) · Oncogene · doi:10.1038/onc.2009.402 · Cited by 214
Self-citationDwight, T., Thoppe, S. R., Foukakis, T., Lui, W. O., Wallin, G., Höög, A., Frisk, T., Larsson, C., & Zedenius, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021690 · Cited by 208
Emerging roles for PAX8 in ovarian cancer and endosalpingeal development
Bowen, N. J., Logani, S., Dickerson, E. B., Kapa, L. B., Akhtar, M., Benigno, B. B., & McDonald, J. F. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.08.052 · Cited by 200
Genetic and Biological Subgroups of Low-Stage Follicular Thyroid Cancer
French, C. A., Alexander, E. K., Cibas, E. S., Nose, V., Laguette, J., Faquin, W., Garber, J., Moore, F., Fletcher, J. A., Larsen, P. R., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63902-8 · Cited by 175
Self-citationIntercepting pelvic cancer in the distal fallopian tube: Theories and realities
Crum, C. P. (2009) · Molecular Oncology · doi:10.1016/j.molonc.2009.01.004 · Cited by 166
Serous Tubal Intraepithelial Carcinoma and the Dominant Ovarian Mass: Clues to Serous Tumor Origin?
Roh, M. H., Kindelberger, D. W., & Crum, C. P. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181868904 · Cited by 133
Mittag, J., Winterhager, E., Bauer, K., & Grümmer, R. (2006) · Endocrinology · doi:10.1210/en.2006-1054 · Cited by 127
Barletta, J. A., Perner, S., Iafrate, A. J., Yeap, B. Y., Weir, B. A., Johnson, L. A., Johnson, B. E., Meyerson, M. M., Rubin, M. A., Travis, W. D., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00594.x · Cited by 109
Self-citationThe role of the PAX8/PPARγ fusion oncogene in the pathogenesis of follicular thyroid cancer
Eberhardt, N. L., Grebe, S. K. G., McIver, B., et al. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.10.013 · Cited by 100
Pax8: A marker for carcinoma of Müllerian origin in serous effusions
Tong, G., Devaraj, K. M., Hamele‐Bena, D., Yu, W. M., Turk, A. T., Chen, X., Wright, J. D., & Greenebaum, E. (2010) · Diagnostic Cytopathology · doi:10.1002/dc.21426 · Cited by 98
Kameda, Y., Ito, M., Nishimaki, T., & Gotoh, N. (2009) · Developmental Dynamics · doi:10.1002/dvdy.21867 · Cited by 39
Cited by
Defining a Cancer Dependency Map
Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Smallridge, R. C., Ain, K. B., Asa, S. L., Bible, K. C., Brierley, J. D., Burman, K. D., Kebebew, E., Lee, N. Y., Nikiforov, Y. E., Rosenthal, M. S., et al. (2012) · Thyroid · doi:10.1089/thy.2012.0302 · Cited by 935
Bible, K. C., Kebebew, E., Brierley, J., Brito, J. P., Cabanillas, M. E., Clark, T. J., Di Cristofano, A., Foote, R., Giordano, T., Kasperbauer, J., et al. (2021) · Thyroid · doi:10.1089/thy.2020.0944 · Cited by 730
Husain, Colby, Ordóñez, Allen, Attanoos, Beasley, Butnor, Chirieac, Churg, Dacic, et al. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0124-ra · Cited by 619
Perets, R., Wyant, G. A., Muto, K. W., Bijron, J. G., Poole, B. B., Chin, K. T., Chen, J. Y. H., Ohman, A. W., Stepule, C. D., Kwak, S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.013 · Cited by 596
Metadata
- Authors
- Laury, A. R., Perets, R., Piao, H., Krane, J. F., Barletta, J. A., French, C., Chirieac, L. R., Lis, R., Loda, M., Hornick, J. L., Drapkin, R., & Hirsch, M. S.
- Venue
- American Journal of Surgical Pathology
- Published
- 2011-06
- Volume
- 35
- Issue
- 6
- Pages
- 816-826
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W2107283089
- Cited by
- 460
- References
- 30
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.